SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-23-000078
Filing Date
2023-08-09
Accepted
2023-08-09 16:04:41
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20230630.htm   iXBRL 10-Q 587579
2 EX-31.1 cntx2023-063010xqexhibit311.htm EX-31.1 10746
3 EX-31.2 cntx2023063010-qexhibit312.htm EX-31.2 10749
4 EX-32.1 cntx2023063010-qexhibit321.htm EX-32.1 6499
  Complete submission text file 0001842952-23-000078.txt   3403680

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20230630.xsd EX-101.SCH 25193
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20230630_cal.xml EX-101.CAL 28533
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20230630_def.xml EX-101.DEF 97190
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20230630_lab.xml EX-101.LAB 428149
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20230630_pre.xml EX-101.PRE 251844
46 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20230630_htm.xml XML 308511
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 231155053
SIC: 2834 Pharmaceutical Preparations